首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Lancet Respiratory Medicine

Lancet Respiratory Medicine杂志,由Elsevier Ltd出版,于2013年创刊,12 issues/year,出版语言English,ISSN:2213-2600,E-ISSN:2213-2619。

投稿咨询
Lancet Respiratory Medicine
Lancet Respiratory Medicine
Lancet Respiratory Medicine
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
34.7
CiteScore
48.1
期刊收录
SCI、SCIE

Lancet Respiratory Medicine(中文译名:《柳叶刀呼吸内科》),ISSN:2213-2600,EISSN:2213-2619,是Elsevier Ltd出版的国际性学术期刊,创刊于2013年,以12 issues/year形式稳定发行,2026年总发文量约75篇。该刊采用非OA开放访问,学科归属为RESPIRATORY SYSTEM - RESPIRATORY SYSTEM。该刊是医学、危重病医学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达34.7,2025年期刊CiteScore为48.1,2025年期刊自引率约1.4%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Lancet Respiratory Medicine长期聚焦医学、危重病医学及相关产业的技术应用前沿,在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、危重病医学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、Canada、GERMANY (FED REP GER)、France、Netherlands、Italy等为核心发文国家与地区;IMPERIAL COLLEGE LONDONUNIVERSITY OF LONDON、HARVARD UNIVERSITY、ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP)、ROYAL BROMPTON HOSPITAL、UNIVERSITY OF CALIFORNIA SYSTEM、UNIVERSITY OF TORONTO等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CRITICAL CARE MEDICINE 危重病医学 RESPIRATORY SYSTEM 呼吸系统
1区 1区
是 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CRITICAL CARE MEDICINE 危重病医学 RESPIRATORY SYSTEM 呼吸系统
1区 1区
是 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CRITICAL CARE MEDICINE 危重病医学 RESPIRATORY SYSTEM 呼吸系统
1区 1区
是 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CRITICAL CARE MEDICINE SCIE Q1 1 / 66

99.2

学科:RESPIRATORY SYSTEM SCIE Q1 1 / 107

99.5

学科:CRITICAL CARE MEDICINE SCIE Q1 1 / 66

99.24

学科:RESPIRATORY SYSTEM SCIE Q1 1 / 107

99.53

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CRITICAL CARE MEDICINE SCIE Q1 1 / 54

99.1

学科:RESPIRATORY SYSTEM SCIE Q1 1 / 100

99.5

学科:CRITICAL CARE MEDICINE SCIE Q1 1 / 55

99.09

学科:RESPIRATORY SYSTEM SCIE Q1 1 / 101

99.5


中国学者近期发文

1
Budesonide-glycopyrronium-formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trial

Author:Papi, Alberto; Wise, Robert A; Jackson, David J; Lugogo, Njira; Chen, Ruchong; Trasieva, Teodora; Obasi, Chidi; Movitz, Charlotta; Helman, Jesse; Salter, Patricia; Springer, Katarzyna; Bondoc, Marco; Shah, Mihir; Knappenberger, Katharine; Bowen, Karin; Pandya, Hitesh; Megally, Ayman; Patel, Mehul

Journal: LANCET RESPIRATORY MEDICINE. 2026; Vol. 14, Issue 4, pp. 350-362. DOI: 10.1016/S2213-2600(25)00457-6

2
Climate change and tuberculosis: an analytical framewor

Author:Saunders, Matthew J.; Boccia, Delia; Khan, Palwasha Y.; Gosce, Lara; Gasparrini, Antonio; Clark, Rebecca A.; Pescarini, Julia M.; Charalambous, Salome; Fekadu, Lelisa; Johansen, Fernanda Dockhorn Da Costa; Vasilyeva, Irina; Narendran, Gopalan; Li, Tao; Ndjeka, Norbert; White, Richard G.; Houben, Rein M. G. J.; Zignol, Matteo; Gebreselassie, Nebiat; Mcquaid, Christopher Finn

Journal: LANCET RESPIRATORY MEDICINE. 2026; Vol. 14, Issue 3, pp. 267-280. DOI: 10.1016/S2213-2600(25)00329-7

3
Blood biomarkers for the prediction of outcome after cardiac arrest: an international prospective observational study within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) tria

Author:Moseby-Knappe, Marion; Levin, Helena; Ullen, Susann; Zetterberg, Henrik; Blennow, Kaj; Lagebrant, Alice; Dankiewicz, Josef; Jakobsen, Janus C.; Lilja, Gisela; Nichol, Alistair D.; Eastwood, Glenn; Ainscough, Kate; Thomas, Matthew J. C.; Grejs, Anders M.; Keeble, Thomas R.; Rylander, Christian; During, Joachim; Wise, Matt P.; Hovdenes, Jan; Storm, Christian; Borgquist, Ola; Cariou, Alain; Deye, Nicolas; Lascarrou, Jean-Baptiste; Bannard-Smith, Jonathan; Unden, Johan; Vignon, Philippe; Legriel, Stephane; Smid, Ondrej; Pogson, David; Karasek, Jiri; McGuigan, Peter J.; Joannidis, Michael; Kirkegaard, Hans; Bewley, Jeremy; Christensen, Steffen; Maccaroni, Maria Rita; Valerianova, Anna; Lundin, Andreas; Lybeck, Anna; Leithner, Christoph; Varhanik, Filip; Sweet, Katie; Walden, Andrew; Friberg, Hans; Cronberg, Tobias; Nielsen, Niklas

Journal: LANCET RESPIRATORY MEDICINE. 2026; Vol. 14, Issue 3, pp. 215-224. DOI: 10.1016/S2213-2600(25)00363-7

4
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a tria

Author:Zhong, Jia; Zhao, Jun; Duan, Jianchun; Fang, Jian; Fei, Kailun; Li, Xiaoyan; Chen, Jiayan; Wang, Zhijie; Chu, Qian; Yu, Yan; Liu, Zhe; Zhang, Li; Zhao, Yanqiu; Li, Xingya; Wu, Lin; Xing, Ligang; Zhuang, Wu; Fang, Xuefeng; Chang, Jianhua; Pan, Yueyin; Dong, Xiaorong; Liu, Lian; Bai, Chunmei; Pan, Pinhua; Song, Qibin; Jin, Bo; Cao, Baoshan; Ye, Feng; Shi, Jianhua; Tang, Kejing; Wang-Gillam, Andrea; Ding, Yuli; Bi, Chao; Shao, Yang; Pang, Jiaohui; Wan, Rui; Sun, Boyang; Xu, Jiachen; Wang, Jie

Journal: LANCET RESPIRATORY MEDICINE. 2026; Vol. 14, Issue 2, pp. 163-173. DOI: 10.1016/S2213-2600(25)00258-9

5
First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3tria

Author:Wang, Lin; Hao, Xuezhi; Hao, Yanrong; Hu, Yanping; Chen, Chun; Chen, Bi; Huang, Yunchao; Zang, Aimin; Wang, Yan; Chen, Zhendong; Zhuang, Wu; Shi, Jinsheng; Ren, Xiubao; Nie, Ligong; Yu, Guohua; Luo, Feng; Mao, Yimin; Wang, Xiang; Li, Baolan; Bai, Yuansong; Shi, Jianhua; Ni, Hongyan; Yu, Haoyu; Li, Jing; Wang, Qingyu; Zhu, Jun; Shi, Yuankai

Journal: LANCET RESPIRATORY MEDICINE. 2026; Vol. 14, Issue 2, pp. 117-128. DOI: 10.1016/S2213-2600(25)00263-2

6
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled tria

Author:Zhong, Nan-Shan; Qiu, Rong; Cao, Jie; Huang, Yan-Ming; Zhou, Hua; Xu, Xing-Xiang; Xu, Jin-Fu; Ye, Huan; Yang, Zhi-Ren; Gao, Ling-Yun; Shen, Yao; Xiao, Zu-Ke; Xie, Shi-Guang; Lin, Dian-Jie; Zhao, Li; Xiong, Hao; Zhang, Xian-Ming; Li, Fang-Qiong; Guan, Wei-Jie; Chalmers, James

Journal: LANCET RESPIRATORY MEDICINE. 2025; Vol. 13, Issue 5, pp. 414-424. DOI: 10.1016/S2213-2600(25)00019-0

7
Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and overtime: a population-based stud

Author:Luo, Ganfeng; Zhang, Yanting; Rumgay, Harriet; Morgan, Eileen; Langselius, Oliver; Vignat, Jerome; Colombet, Murielle; Bray, Freddie

Journal: LANCET RESPIRATORY MEDICINE. 2025; Vol. 13, Issue 4, pp. 348-363. DOI: 10.1016/S2213-2600(24)00428-4

8
An overview of influenza H5 vaccine

Author:Taaffe, Jessica; Zhong, Shuyi; Goldin, Shoshanna; Rawlings, Kate S.; Cowling, Benjamin J.; Zhang, Wenqing

Journal: LANCET RESPIRATORY MEDICINE. 2025; Vol. 13, Issue 4, pp. e20-e21. DOI: 10.1016/S2213-2600(25)00052-9

9
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 stud

Author:Shi, Yuankai; Guo, Yanzhen; Li, Xingya; Wu, Lin; Chen, Zhaohong; Yang, Sheng; Bi, Minghong; Zhao, Yanqiu; Yao, Wenxiu; Yu, Huiqing; Yu, Huiqing; Wang, Ke; Zhao, Wenhua; Sun, Meili; Zhang, Liangming; He, Zhiyong; Lin, Yingcheng; Shi, Jianhua; Zhu, Bo; Wang, Lijun; Pan, Yueyin; Shi, Huaqiu; Sun, Shenghua; Wen, Meiling; Zhou, Rui; Guo, Shuliang; Han, Zhigang; Yi, Tienan; Zhang, Hua; Cang, Shundong; Yu, Zhuang; Zhong, Diansheng; Cui, Jiuwei; Fang, Jian; Gao, Jinghua; Li, Manxiang; Ma, Rui; Jiang, Mingyan; Qin, Jianwen; Shu, Yongqian; Ye, Feng; Hu, Sheng; Li, Wen; Lu, Hong; Yang, Minglei; Yi, Shanyong; Zhang, Yan; Fan, Yun; Ji, Hongbo; Liu, Zheng; Wang, Haitao; Zhou, Xiangdong; Zhang, Don; Peng, Jirong; Shen, Haijiao; Gao, Feng; Wang, Tingting; Zhou, Anqi

Journal: LANCET RESPIRATORY MEDICINE. 2025; Vol. 13, Issue 4, pp. 327-337. DOI: 10.1016/S2213-2600(24)00417-X


在线咨询

Lancet Respiratory Medicine

国际简称:LANCET RESP MED参考译名:柳叶刀呼吸内科

年发文量:75 CiteScore:48.1 是否预警:否 Gold OA文章占比:19.32% 研究类文章占比:92.00%

杂志社联系方式:THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB

Lancet Respiratory Medicine